Cost-effectiveness analysis of pharmacogenomics (PGx)-based warfarin, apixaban, and rivaroxaban versus standard warfarin for the management of atrial fibrillation …

A Hafeez, LE Cipriano, RB Kim, GS Zaric… - …, 2024 - Springer
Objective To assess the cost-effectiveness of pharmacogenomics (PGx)-based warfarin (ie,
warfarin dosing following genetic testing), apixaban, and rivaroxaban oral anticoagulation …

Fibrinaloid Microclots and Atrial Fibrillation

DB Kell, GYH Lip, E Pretorius - Biomedicines, 2024 - mdpi.com
Atrial fibrillation (AF) is a comorbidity of a variety of other chronic, inflammatory diseases for
which fibrinaloid microclots are a known accompaniment (and in some cases, a cause, with …